Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2016 Financial Results on February 27, 2017
February 20 2017 - 4:05PM
Novavax, Inc. (Nasdaq:NVAX) today announced it will report its
fourth quarter and full year 2016 financial and operating results
following the close of U.S. financial markets on Monday, February
27, 2017.
Conference call details are as follows:
| Date: |
|
Monday, February 27,
2017 |
| Time: |
|
4:30 p.m. U.S. Eastern
Time (ET) |
| Dial-in number: |
|
(877) 212-6076
(Domestic) or (707) 287-9331 (International) |
| Passcode: |
|
61206704 |
| Webcast: |
|
www.novavax.com,
“Investors”/ “Events” |
| |
|
|
Conference call and webcast replay:
| Dates: |
|
Starting at 7:30 p.m.
ET, February 27, 2017, until midnight March 3, 2017 |
| Dial-in number: |
|
(855) 859-2056
(Domestic) or (404) 537-3406 (International) |
| Passcode: |
|
61206704 |
| Webcast: |
|
www.novavax.com,
“Investors”/ “Events”, until April 30, 2017 |
| |
|
|
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage
biotechnology company committed to delivering novel products to
prevent a broad range of infectious diseases. Its recombinant
nanoparticles and Matrix-M™ adjuvant technology are the foundation
for groundbreaking innovation that improves global health through
safe and effective vaccines.
Contact:
Investor Relations
Novavax, Inc.
Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations
ir@novavax.com
240-268-2000
Westwicke Partners
John Woolford
john.woolford@westwicke.com
443-213-0506
Media
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull@russopartnersllc.com
212-845-4271
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024
